1. The American Medical Association issued a CPT add-on code for the second level in lumbar total disc procedures.
2. A long-term study of Saluda Medical’s Evoke spinal cord stimulator found most patients had significant pain reduction and no explants.
3. VySpine’s LumiVy NanoVy Ti lumbar interbody fusion system earned FDA clearance.
4. Lipogems enrolled the first patient in a U.S. study focusing on MicroFat injections in knee osteoarthritis.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
